A detailed history of Qube Research & Technologies LTD transactions in Nevro Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 18,190 shares of NVRO stock, worth $151,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,190
Holding current value
$151,886
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$13.56 - $20.78 $246,656 - $377,988
18,190 New
18,190 $262,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $1.26 Million - $1.71 Million
34,606 New
34,606 $1.37 Million
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $789,222 - $1.5 Million
19,320 Added 97.96%
39,042 $1.71 Million
Q1 2022

May 09, 2022

SELL
$59.95 - $92.06 $496,805 - $762,901
-8,287 Reduced 29.59%
19,722 $1.43 Million
Q4 2021

Feb 01, 2022

BUY
$81.07 - $121.29 $2.27 Million - $3.4 Million
28,009 New
28,009 $2.27 Million
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $379,198 - $618,526
-3,718 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$141.6 - $179.06 $526,468 - $665,745
3,718 New
3,718 $616,000
Q1 2021

May 14, 2021

SELL
$132.81 - $182.18 $588,348 - $807,057
-4,430 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $97,548 - $130,144
706 Added 18.96%
4,430 $767,000
Q3 2020

Nov 12, 2020

BUY
$114.09 - $145.51 $424,871 - $541,879
3,724 New
3,724 $519,000
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $274,037 - $563,097
-3,902 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$76.41 - $117.54 $298,151 - $458,641
3,902 New
3,902 $459,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $295M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.